Pemetrexed in combination with cisplatin in the first-line
treatment of non-squamous NSCLC: Czech experience with 233
patients

a 2013

Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients

SKŘIČKOVÁ, Jana; Zbyněk BORTLÍČEK; Karel HEJDUK; Miloš PEŠEK; Vítězslav KOLEK et al.

Základní údaje

Originální název

Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients

Autoři

Vydání

15th World Conference on Lung Cancer, October 27 - 30, 2013, Sydney, Australia, 2013

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30203 Respiratory systems

Stát vydavatele

Austrálie

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 5.800

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/13:00070496

Organizační jednotka

Lékařská fakulta

ISSN

UT WoS

000339624904114

Klíčová slova anglicky

first-line treatment; NSCLC

Změněno: 18. 2. 2014 14:28, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

In a group of 233 patients with advanced non-squamous NSCLC who were treated with pemetrexed in first line and in combination with cisplatin, the therapy was well tolerated: termination of treatment due to adverse events was reported only in 3.8% of patients. Median overall was 11.6 months, median progression-free survival was 4.2 months.

Citovat

SKŘIČKOVÁ, Jana; Zbyněk BORTLÍČEK; Karel HEJDUK; Miloš PEŠEK; Vítězslav KOLEK; Jaromír ROUBEC; Marcela TOMÍŠKOVÁ; Monika ŠATÁNKOVÁ; Zdenka POVOLNÁ; Helena ČOUPKOVÁ; František SALAJKA; Dimka SIXTOVÁ; Leona KOUBKOVÁ; Libor HAVEL; Michal HRNCIARIK; Milada ZEMANOVÁ a Markéta ČERNOVSKÁ. Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients. In 15th World Conference on Lung Cancer, October 27 - 30, 2013, Sydney, Australia. 2013. ISSN 1556-0864.

@proceedings{1136260,
   author = {Skřičková, Jana and Bortlíček, Zbyněk and Hejduk, Karel and Pešek, Miloš and Kolek, Vítězslav and Roubec, Jaromír and Tomíšková, Marcela and Šatánková, Monika and Povolná, Zdenka and Čoupková, Helena and Salajka, František and Sixtová, Dimka and Koubková, Leona and Havel, Libor and Hrnciarik, Michal and Zemanová, Milada and Černovská, Markéta},
   booktitle = {15th World Conference on Lung Cancer, October 27 - 30, 2013, Sydney, Australia},
   keywords = {first-line treatment; NSCLC},
   language = {eng},
   title = {Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients},
   year = {2013}
}

TY  - CONF
ID  - 1136260
AU  - Skřičková, Jana - Bortlíček, Zbyněk - Hejduk, Karel - Pešek, Miloš - Kolek, Vítězslav - Roubec, Jaromír - Tomíšková, Marcela - Šatánková, Monika - Povolná, Zdenka - Čoupková, Helena - Salajka, František - Sixtová, Dimka - Koubková, Leona - Havel, Libor - Hrnciarik, Michal - Zemanová, Milada - Černovská, Markéta
PY  - 2013
TI  - Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients
KW  - first-line treatment
KW  - NSCLC
N2  - In a group of 233 patients with advanced non-squamous NSCLC who were treated with pemetrexed in first line and in combination with cisplatin, the therapy was well tolerated: termination of treatment due to adverse events was reported only in 3.8% of patients. Median overall was 11.6 months, median progression-free survival was 4.2 months.
ER  -

SKŘIČKOVÁ, Jana; Zbyněk BORTLÍČEK; Karel HEJDUK; Miloš PEŠEK; Vítězslav KOLEK; Jaromír ROUBEC; Marcela TOMÍŠKOVÁ; Monika ŠATÁNKOVÁ; Zdenka POVOLNÁ; Helena ČOUPKOVÁ; František SALAJKA; Dimka SIXTOVÁ; Leona KOUBKOVÁ; Libor HAVEL; Michal HRNCIARIK; Milada ZEMANOVÁ a Markéta ČERNOVSKÁ. Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients. In \textit{15th World Conference on Lung Cancer, October 27 - 30, 2013, Sydney, Australia}. 2013. ISSN~1556-0864.

Přehled o publikaci